GeneTex

  • Country / Location Selection

United States (US)

West Nile virus Envelope Peptide

Cat. No. GTX85507-PEP

Application

 Neutralizing/Inhibition

Species

 West Nile virus
Package
50 μg ($139)
See all West Nile virus Envelope products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH7.2, 10mM NaH₂PO₄, 10mM Na₂HPO₄, 130mM NaCl, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store the peptide at -20ºC, stable for one year.

Concentration

0.20 mg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

West Nile virus Envelope protein , WNV Envelope protein

Background

West Nile virus peptide is used for blocking the activity of West Nile virus envelope antibody (Cat. No. GTX85507). It usually blocks the West Nile Virus antibody activity completely in ELISA by incubating the peptide with equal volume of antibody for 30 min at 37oC.

Research Area

REFERENCE

There are currently no references for West Nile virus Envelope Peptide (GTX85507-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for West Nile virus Envelope Peptide (GTX85507-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139